Can’t see the audio player? Click here to listen on SoundCloud. Listen to Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts.
Parliamentary and White House Democrats have threatened many of President Joe Biden’s domestic agendas, despite Republicans threatening to shut down the government and fail to meet national debt, despite many opposition to increased spending. We are enthusiastically negotiating to pass the agreement to the extent that we can agree.
Meanwhile, confusion over the so-called booster shots of covid-19 continues, and supporters on both sides of the abortion controversy are trying to test Texas’s new abortion law, which the Supreme Court has allowed to come into effect on September 1. increase.
This week’s panelists are Julie Rovner from KHN, Joanne Kenen from Politico, Mary Ellen McIntire from CQ Roll Call, and Sarah Karlin-Smith from Pink Sheet.
Among the points from this week’s episode:
- The bet is enormous, as Democrats are working to please the various factions of the party with a huge “human infrastructure” bill. The bill contains dozens of major policy changes, each of which could be subject to major legislation that would have taken months to negotiate in the last few years. Failure to reach sufficient agreement to pass the bill could have serious implications for the party and the Biden administration in the next election round.
- One of the major disagreements about health policy in the law is what Congress can do to keep prescription drug prices down. Negotiations are underway, but Senator Ron Wyden (D-Ore.), Who holds a strong hand in the final deal as chairman of the Finance Commission, is close to his chest about what he will help. I have his card in.
- Despite the rhetoric over drug prices, Democratic factions do not seem to oppose all curbs. The controversy is how and how much to limit price increases.
- The pharmaceutical industry expects to hit the bill, but uses a wide range of advertising campaigns to highlight the need for funding to make medical innovations. However, the general public seems to want both low prices and better drug options. In addition, consumer advocates note that not all incentives for current systems are directed towards innovation, and in many cases only minor drug improvements are rewarded.
- The current turmoil about when and who should get additional Covid shots is confusing Americans. Centers for Disease Control and Prevention officials seem to want a more cohesive strategy of not picking out specific vaccines, but the White House push earlier this month added pressure to move those shots.
- One of the biggest obstacles to vaccinating people in developing countries is supply shortages, so the United States has promised to vaccinate more in developing countries this week. However, the logistical problem is very imminent.
Also this week, Robner will interview Dr. Scott Gottlieb, a former member of the Food and Drug Administration. He has a new book entitled “Uncontrolled Spread: Why COVID-19 Crushed Us and How to Defeat the Next Pandemic.”
In addition, as an additional credit, panelists recommend talking about your favorite health policy for the week, which you also think you should read.
Julie Robner: “Their baby died in the hospital, and then received a $ 257,000 invoice,” said Sarah Kliff of the New York Times.
Joan Kenen: New Yorker’s “Struggle to Define Long Covid”, Dhruv Khullar
Mary Ellen McIntyre: Dr. Will of KHN. Have you ever faced disinformation with music? Victoria Night
Sarah Carlin-Smith: The Washington Post “The world’s tallest population is declining and scientists want to know why,” Rachel Panett
Click here to hear all the podcasts.
And would you like to subscribe to KHN’s What the Health? Wherever you listen to Spotify, Apple Podcasts, Stitcher, Pocket Casts, or podcasts.
We encourage organizations to republish content for free. This is what we want:
You must credit as the original publisher using the hyperlink to the khn.org site. If possible, include the author and “Kaiser Health News” in the byline. Save the hyperlink in the story.
It is important to note that not all of khn.org can be republished. If your story is labeled “All Rights Reserved,” you cannot grant permission to republish the item.
do you have any questions? Please let us know at KHNHelp@kff.org
KHN’s “What the Health?”: Democratic Fall of Dissatisfaction
Source link KHN’s “What the Health?”: Democratic Fall of Dissatisfaction